Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 28.39
-2.27 %
$ 894 M
Market Cap
15.26
P/E
Price Target
Average
47.44%
Revenue Forecast
Estimate
3.94%
EBIT
Estimate
--26.21%
Net Income
Estimate
55.70%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Collegium Pharmaceutical, Inc.
Wall Street analysts predict an average 1-year price target for COLL of $41.9 , with forecasts ranging from
a
low of
$36 to a high of $50 .
COLL Lowest Price Target
Wall Street Target
36 USD
26.81%
COLL Average Price Target
Wall Street Target
41.9 USD
47.44%
COLL Highest Price Target
Wall Street Target
50 USD
76.12%
REVENUE FORECAST
Revenue Forecast Chart COLL
EBIT FORECAST
EBIT Forecast Chart COLL
NET INCOME FORECAST
Net Income Chart COLL